Rifamycin antibiotic

Rifadin (rifampin)

Also marketed as Rimactane. An approved treatment for Bartonellosis.

FDA Approved (1971)
Preclinical
Phase 1
Phase 2
Phase 3
Approved
1971
Drug facts

The same compound appears under different names depending on the context. Here is how to identify Rifampin wherever you encounter it, plus the key facts at a glance.

Generic name
Rifampin
Brand names
Rifadin, Rimactane
Drug class
Rifamycin antibiotic
How it's taken
For bartonellosis, rifampin is typically given 300 mg orally twice daily as part of a combination regimen (often with doxycycline or azithromycin).

A rifamycin antibiotic used in combination regimens for Bartonella infections, particularly for neurobartonellosis and endocarditis. Its ability to penetrate biofilms makes it relevant for chronic bartonellosis.

How Rifampin works

Rifampin inhibits bacterial DNA-dependent RNA polymerase, blocking RNA synthesis at the transcription level. It achieves high intracellular concentrations and can penetrate biofilm structures, which is why some practitioners include it in combination regimens for chronic Bartonella infections where biofilm persistence is suspected.

Mechanism: Rifamycin antibiotic that inhibits bacterial DNA-dependent RNA polymerase

Side effects and safety

What patients report

Rifampin turns body fluids (urine, tears, sweat) orange-red, which is harmless but can stain contact lenses and clothing. It is a potent CYP3A4 inducer and accelerates the metabolism of many drugs including oral contraceptives, warfarin, HIV protease inhibitors, and immunosuppressants. Drug interaction review is essential before starting rifampin. Liver injury, which can be severe enough to cause liver failure and death, is a key risk, and liver function monitoring is recommended. The label also warns about serious allergic reactions and severe skin reactions (including Stevens-Johnson syndrome and DRESS), thrombotic microangiopathy (small blood clots that damage the kidneys and blood cells, sometimes fatal), lung inflammation that can be fatal, bleeding problems from low vitamin K, and flares of porphyria. Rifampin must not be taken with certain HIV medicines (atazanavir, darunavir, fosamprenavir, saquinavir, tipranavir, cabotegravir, fostemsavir or lenacapavir), with praziquantel, or with lurasidone (a medicine for schizophrenia and bipolar disorder).

This is not a complete list of side effects. Talk to your doctor or pharmacist about what to expect and when to seek medical attention.

Taking Rifampin

For bartonellosis, rifampin is typically given 300 mg orally twice daily as part of a combination regimen (often with doxycycline or azithromycin). Duration varies from 2 weeks for uncomplicated infection to 3 to 6 months for endocarditis or neurobartonellosis. Should be taken on an empty stomach for best absorption. In the US, rifampin is now sold mainly as generics: brand-name Rifadin capsules have been discontinued, and Sanofi has stopped making Rifadin IV, temporarily importing a UK version during a shortage.

Availability and cost

Generic available

Generic versions may be available at a lower cost. Ask your pharmacist.

Help paying for Rifadin

Pick your insurance to see which help fits. Drugmaker copay cards can't be used with Medicare, Medicaid or TRICARE; charity funds are the usual route there.

Your insurance
From the drugmaker
Rifadin (Rifampin)

No drugmaker assistance program for this medicine is published on the maker's official pages.

Good to know: Rifampin is an older antibiotic sold as a low-cost generic by many manufacturers. There is no single manufacturer assistance program for it. Pharmacy discount programs or a pharmacist can help with cost.

Checked on the drugmaker's official pages on September 24, 2026. Programs change; confirm with the program before you rely on it.

More ways to get help paying for treatment →

Ask anything about Rifampin
AI-powered answers from clinical trial databases, FDA reports, and medical literature
Tap to start:
Or start with one of these

Explore Bartonellosis trials

Other Bartonellosis treatments

Common questions about Rifampin

▸What is Rifampin (Rifadin)?

A rifamycin antibiotic used in combination regimens for Bartonella infections, particularly for neurobartonellosis and endocarditis. Its ability to penetrate biofilms makes it relevant for chronic bartonellosis.

▸How does Rifampin work?

Rifampin inhibits bacterial DNA-dependent RNA polymerase, blocking RNA synthesis at the transcription level. It achieves high intracellular concentrations and can penetrate biofilm structures, which is why some practitioners include it in combination regimens for chronic Bartonella infections where biofilm persistence is suspected.

▸What are the side effects of Rifampin?

Rifampin turns body fluids (urine, tears, sweat) orange-red, which is harmless but can stain contact lenses and clothing. It is a potent CYP3A4 inducer and accelerates the metabolism of many drugs including oral contraceptives, warfarin, HIV protease inhibitors, and immunosuppressants. Drug interaction review is essential before starting rifampin. Liver injury, which can be severe enough to cause liver failure and death, is a key risk, and liver function monitoring is recommended. The label also warns about serious allergic reactions and severe skin reactions (including Stevens-Johnson syndrome and DRESS), thrombotic microangiopathy (small blood clots that damage the kidneys and blood cells, sometimes fatal), lung inflammation that can be fatal, bleeding problems from low vitamin K, and flares of porphyria. Rifampin must not be taken with certain HIV medicines (atazanavir, darunavir, fosamprenavir, saquinavir, tipranavir, cabotegravir, fostemsavir or lenacapavir), with praziquantel, or with lurasidone (a medicine for schizophrenia and bipolar disorder).

▸How is Rifampin taken?

For bartonellosis, rifampin is typically given 300 mg orally twice daily as part of a combination regimen (often with doxycycline or azithromycin). Duration varies from 2 weeks for uncomplicated infection to 3 to 6 months for endocarditis or neurobartonellosis. Should be taken on an empty stomach for best absorption. In the US, rifampin is now sold mainly as generics: brand-name Rifadin capsules have been discontinued, and Sanofi has stopped making Rifadin IV, temporarily importing a UK version during a shortage.

▸Is Rifampin FDA approved?

Yes, Rifampin (Rifadin) is FDA approved (1971) for the treatment of Bartonellosis.

This page is for informational purposes only and does not constitute medical advice. Drug information is sourced from public databases and peer-reviewed literature and may not reflect the most recent updates. Always discuss treatment options with your healthcare provider. Last reviewed: September 2026.

Follow Rifampin (Rifadin) news by email

One email when Rifampin (Rifadin) has trial changes, FDA news, or label updates for its condition. No newsletter, no spam.

We never share your email. Unsubscribe anytime.